News | September 02, 2023
Biocon acquires oral solid dosage manufacturing facility of Eywa Pharma for US$7.7 million
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
The approval bolsters the company's Mycophenolate Mofetil portfolio
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
This product will be manufactured at Lupin's Pithampur facility in India
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
Subscribe To Our Newsletter & Stay Updated
